Regulator targets fake drugs sold on internet


The medicines watchdog is to step up covert internet purchases and testing of suspect pharmaceuticals as part of a new strategy to be unveiled on Thursday.

Michael Deats, head of enforcement at the Medicines and Healthcare products Regulatory Agency, told the FT that he planned more testing of patented drugs, as well as strengthening of generic drugs testing, tougher criminal sentencing, greater cross-border police co-operation and introduction of 24-hour telephone hotlines.

By Andrew Jack
22 November 2007

Read the full story at ft.com.